Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
When Curtain Falls: 4+7 To 4+N Signals End To Branded Generics In China?
Aug 12 2019
•
By
Brian Yang
EXPANSION OF SHANGHAI-INITIATED '4+7' SCHEME TO BRING PRICE PRESSURE ON BRANDED GENERICS • Source: Shutterstock
More from China
More from Focus On Asia